LATIN AMERICA DRUG DISCOVERY MARKET 2019-2027


MARKET OUTLOOK
According to Triton Market Research’s analysis, the Latin America drug discovery market is anticipated to register a CAGR of 7.65% for the forecasted period of 2019-2027.
Mexico, Brazil, and Rest of Latin American countries are studied for the drug discovery market in the Latin America region.
The gradual rise in healthcare expenses has been helping pharmaceutical technology advancement and driving the drug discovery market in Latin America. For instance, there has been an increase in the usage of advanced technologies such as high throughput screening (HTS), spectroscopy, combinational chemistry, and bioinformatics for better drug identification.
Many pharmaceutical companies in Mexico have started shifting to personalized medicine to address the high mortality rate of cancer in the country. This approach is anticipated to contribute to the drug discovery process and create significant growth opportunities for the market. Academic communities have also started using HTS procedures to find potential drugs by collaborating with the government.
Due to the less investment, time, and risk, drug discovery is expected to be practiced largely in small niche biopharmaceutical companies. A large portion of the population in need of targeted drug delivery has been stimulating the government and local pharmaceutical labs to take up the initiative. It is predicted that the collaboration with contract development and manufacturing organizations would reduce the time and cost for big pharmaceutical companies to increase the market and further boost the growth of the drug discovery market.
COMPETITIVE OUTLOOK
The key players in the drug discovery market are AstraZeneca plc, Bayer AG, Becton, Dickinson and Company (BD), Boehringer Ingelheim, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc and Pfizer Inc.
TABLE OF CONTENTS 
1. LATIN AMERICA DRUG DISCOVERY MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREATS OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. COMPETITIVE RIVALRY
2.3. PESTLE OUTLOOK
2.4. VALUE CHAIN OUTLOOK
2.5. MARKET ATTRACTIVENESS INDEX
2.6. KEY INSIGHT
2.7. MARKET DRIVERS
2.7.1. GROWING AGED POPULATION
2.7.2. TECHNOLOGICAL ADVANCEMENTS
2.7.3. RISE IN THE HEALTHCARE EXPENDITURE
2.7.4. SURGE IN LIFESTYLE-ORIENTED DISEASES
2.8. MARKET RESTRAINTS
2.8.1. DELAY IN PRODUCT LAUNCHES
2.8.2. RESTRICTING GROWTH RATE OF A DRUG DUE TO GENERIC DRUGS
2.9. MARKET OPPORTUNITIES
2.9.1. SIGNIFICANT INVESTMENT BY HEALTHCARE INDUSTRIES IN IMPROVING BIG-DATA ANALYTICAL CAPABILITIES
2.9.2. RISING DEMAND FOR SPECIALTY MEDICINES
2.10. MARKET CHALLENGES
2.10.1. STRINGENT GOVERNMENT REGULATIONS
3. DRUG DISCOVERY MARKET OUTLOOK – BY DRUG TYPE
3.1. SMALL MOLECULE DRUG
3.2. BIOLOGIC DRUG
4. DRUG DISCOVERY MARKET OUTLOOK – BY TECHNOLOGY
4.1. HIGH THROUGHPUT SCREENING
4.2. BIOCHIPS
4.3. BIOINFORMATICS
4.4. PHARMACOGENOMICS AND PHARMACOGENETICS
4.5. COMBINATORIAL CHEMISTRY
4.6. NANOTECHNOLOGY
4.7. SPECTROSCOPY
4.8. METABOLOMICS
4.9. OTHER TECHNOLOGIES
5. DRUG DISCOVERY MARKET OUTLOOK – BY SERVICE
5.1. DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
5.2. CHEMICAL SERVICES
5.3. BIOLOGICAL SERVICES
5.4. OTHER PHARMACEUTICAL SERVICES
6. DRUG DISCOVERY MARKET OUTLOOK – BY END-USER
6.1. RESEARCH INSTITUTES
6.2. PHARMACEUTICAL COMPANIES
6.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)
6.4. OTHER END-USERS
7. DRUG DISCOVERY MARKET – REGIONAL OUTLOOK
7.1. LATIN AMERICA
7.1.1. COUNTRY ANALYSIS
7.1.1.1. BRAZIL
7.1.1.2. MEXICO
7.1.1.3. REST OF LATIN AMERICA
8. COMPANY PROFILES
8.1. 3M COMPANY
8.2. ABBOTT LABORATORIES INC.
8.3. AGILENT TECHNOLOGIES, INC.
8.4. ANTARES PHARMA
8.5. ASTRAZENECA PLC
8.6. BAYER AG
8.7. BECTON, DICKINSON AND COMPANY (BD)
8.8. BOEHRINGER INGELHEIM
8.9. ELI LILY AND COMPANY
8.10. F. HOFFMANN-LA ROCHE LTD.
8.11. GLAXOSMITHKLINE LLC
8.12. JOHNSON & JOHNSON
8.13. MERCK & CO., INC.
8.14. NOVARTIS
8.15. PFIZER, INC.
8.16. SANOFI
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS
 
LIST OF TABLES 
TABLE 1 LATIN AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
TABLE 2 LATIN AMERICA DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2027 ($ MILLION)
TABLE 3 LATIN AMERICA DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
TABLE 4 LATIN AMERICA DRUG DISCOVERY MARKET, BY SERVICE, 2019-2027 ($ MILLION)
TABLE 5 LATIN AMERICA DRUG DISCOVERY MARKET, BY END-USER, 2019-2027 ($ MILLION)
TABLE 6 LATIN AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
 
 
LIST OF FIGURES 
FIGURE 1 LATIN AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 2 LATIN AMERICA DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2027 ($ MILLION)
FIGURE 3 LATIN AMERICA DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2027 ($ MILLION)
FIGURE 4 LATIN AMERICA DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 ($ MILLION)
FIGURE 5 LATIN AMERICA DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2027 ($ MILLION)
FIGURE 6 LATIN AMERICA DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2027 ($ MILLION)
FIGURE 7 LATIN AMERICA DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2027 ($ MILLION)
FIGURE 8 LATIN AMERICA DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2027 ($ MILLION)
FIGURE 9 LATIN AMERICA DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2027 ($ MILLION)
FIGURE 10 LATIN AMERICA DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2027 ($ MILLION)
FIGURE 11 LATIN AMERICA DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2027 ($ MILLION)
FIGURE 12 LATIN AMERICA DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2027 ($ MILLION)
FIGURE 13 LATIN AMERICA DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2027 ($ MILLION)
FIGURE 14 LATIN AMERICA DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 15 LATIN AMERICA DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 16 LATIN AMERICA DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 17 LATIN AMERICA DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)
FIGURE 18 LATIN AMERICA DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2027 ($ MILLION)
FIGURE 19 LATIN AMERICA DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2027 ($ MILLION)
FIGURE 20 LATIN AMERICA DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2019-2027 ($ MILLION)
FIGURE 21 BRAZIL DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 22 MEXICO DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 23 REST OF LATIN AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

LIST OF TABLES TABLE 1 LATIN AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) TABLE 2 LATIN AMERICA DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2027 ($ MILLION) TABLE 3 LATIN AMERICA DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION) TABLE 4 LATIN AMERICA DRUG DISCOVERY MARKET, BY SERVICE, 2019-2027 ($ MILLION) TABLE 5 LATIN AMERICA DRUG DISCOVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) TABLE 6 LATIN AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) LIST OF FIGURES FIGURE 1 LATIN AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) FIGURE 2 LATIN AMERICA DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2027 ($ MILLION) FIGURE 3 LATIN AMERICA DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2027 ($ MILLION) FIGURE 4 LATIN AMERICA DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 ($ MILLION) FIGURE 5 LATIN AMERICA DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2027 ($ MILLION) FIGURE 6 LATIN AMERICA DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2027 ($ MILLION) FIGURE 7 LATIN AMERICA DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2027 ($ MILLION) FIGURE 8 LATIN AMERICA DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2027 ($ MILLION) FIGURE 9 LATIN AMERICA DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2027 ($ MILLION) FIGURE 10 LATIN AMERICA DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2027 ($ MILLION) FIGURE 11 LATIN AMERICA DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2027 ($ MILLION) FIGURE 12 LATIN AMERICA DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2027 ($ MILLION) FIGURE 13 LATIN AMERICA DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2027 ($ MILLION) FIGURE 14 LATIN AMERICA DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2027 ($ MILLION) FIGURE 15 LATIN AMERICA DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2027 ($ MILLION) FIGURE 16 LATIN AMERICA DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2027 ($ MILLION) FIGURE 17 LATIN AMERICA DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION) FIGURE 18 LATIN AMERICA DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2027 ($ MILLION) FIGURE 19 LATIN AMERICA DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2027 ($ MILLION) FIGURE 20 LATIN AMERICA DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2019-2027 ($ MILLION) FIGURE 21 BRAZIL DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) FIGURE 22 MEXICO DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) FIGURE 23 REST OF LATIN AMERICA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Pharmaceuticals and Healthcare Reports

Other Reports by Triton Market Research

THE UNITED STATES HAIR CARE MARKET 2019-2025

MARKET OUTLOOK The market for hair care in the United States is projected to expand with 1.14% of CAGR in the forecasting period of 2019-2025. The “ethnic hair care” category in the US is going through a massive shift. The sales of relaxants have...

INDIA HAIR CARE MARKET 2019-2025

MARKET OUTLOOK The market for hair care in India has been anticipated to upsurge with 1.57% of CAGR in the forecasting years of 2019-2025. The middle-class population formed a significant consumer base for hair care products in the India market; this...

FRANCE HAIR CARE MARKET 2019-2025

MARKET OUTLOOK Triton Market Research speculates the France hair care market to witness -0.10% of CAGR during the forecast years of 2019-2025. The mature hair care category continued to be affected by pressure on prices, particularly in the mass dist...

CHINA HAIR CARE MARKET 2019-2025

MARKET OUTLOOK The China hair care market is expected to display an upward trend and is estimated to grow at a CAGR of 0.94% in terms of revenue over the forecast duration of 2019 to 2025. With increasing public awareness for personal grooming and th...

BRAZIL HAIR CARE MARKET 2019-2025

MARKET OUTLOOK The Brazilian hair care market is expected to proliferate at a CAGR of 3.18% during the forecasting period between 2019 and 2025. Salon hair care in Brazil has witnessed fast growth. Despite registering a volume decline, this category ...

Publisher: Triton Market Research